Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:03:08 EDT Thu 14 May 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:BCT - BRIACELL THERAPEUTICS CORP. J - https://www.briacell.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BCT - T  0.15.60·5.730.15.72    51.50  4.95May 1307:3015 min RT 2¢
TSX - T0.15.60·5.730.15.72    51.50  4.95May 1315 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-05-14 07:30C:BCT5.72News ReleaseBriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+(TM) for Prostate Cancer
2026-05-13 07:30C:BCT5.58News ReleaseBriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
2026-05-12 17:54C:BCT5.58News ReleaseBriacell's Bria-ABC enrolment surpasses 230 patients
2026-05-07 16:41C:BCT5.60News ReleaseBriacell adds NYU site to phase 3 breast study
2026-05-06 17:29C:BCT5.63News ReleaseBriacell gets FDA clearance to start Bria-BRES+ study
2026-04-27 17:16C:BCT5.48News ReleaseBriacell to make six data presentations at ASCO
2026-04-21 17:43C:BCT5.42News ReleaseBriacell to release Bria-OTS+ data April 21
2026-04-20 17:41C:BCT5.49News ReleaseBriacell shows QoL data, biomarkers at AACR
2026-03-31 20:55C:BCT5.75News ReleaseBriacell completes licence acquisition by BriaPro
2026-03-31 15:23C:BCTSEDAR Early Warning ReportSEDAR Early Warning Report
2026-03-18 07:30C:BCT6.22News ReleaseBriaCell to Present Positive Clinical Data for Bria-IMT(TM) and Preclinical Data for Next Generation Bria-OTS+(TM) Personalized Immunotherapy at the 2026 AACR Conference
2026-03-10 17:30C:BCT5.09SEDAR Interim MD & ASEDAR Interim MD & A
2026-03-10 17:29C:BCT5.09SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-03-10 07:30C:BCT5.07News ReleaseBriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
2026-03-05 18:34C:BCT5.47News ReleaseBriacell shareholders approve all matters at AGSM
2026-02-18 17:30C:BCT5.45News ReleaseBriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
2026-02-17 18:29C:BCT5.40News ReleaseBriacell receives recommendation from safety board
2026-01-28 07:30C:BCT6.70News ReleaseBriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
2026-01-27 07:30C:BCT6.38News ReleaseBriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
2026-01-15 16:05C:BCT6.74News ReleaseBriaCell Therapeutics Announces Closing of US$30 million Public Offering